Before piling into Woodford Patient Capital Trust, read this

Does the current 30%+ discount to NAV make Woodford Patient Capital Trust plc (LON: WPCT) a buy?

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

When investing, your capital is at risk. The value of your investments can go down as well as up and you may get back less than you put in.

Read More

The content of this article is provided for information purposes only and is not intended to be, nor does it constitute, any form of personal advice. Investments in a currency other than sterling are exposed to currency exchange risk. Currency exchange rates are constantly changing, which may affect the value of the investment in sterling terms. You could lose money in sterling even if the stock price rises in the currency of origin. Stocks listed on overseas exchanges may be subject to additional dealing and exchange rate charges, and may have other tax implications, and may not provide the same, or any, regulatory protection as in the UK.

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More.

Is the recent move down in the share price of Woodford Patient Capital Trust (LSE: WPCT) justified, or is it an over-reaction to trouble in the Woodford Equity Income fund? If the move is a knee-jerk reaction by the market, does the big discount to net asset value make the stock a bargain?

The shock news this month that Woodford Investment Management has suspended dealings in its Equity Income fund seems to have dragged everything Woodford-related lower, including shares in WPCT. But let’s remember the trend in the shares has been down for some time, and I think there are good reasons for that.

Probabilities playing out in the trust?

When the share price was around 75p in May 2018, I argued that the probabilities were playing out among the trust’s speculative investee companies. As long as the trust doesn’t invest in any more profitless, jam-tomorrow firms, maybe the potential Woodford believes is in the portfolio will go on to shine through. Meanwhile, the losers could already have declined sufficiently to become less of a problem.

On that basis, I was cautiously optimistic about the trust’s prospects. However, all that has changed. Woodford’s reputation as a stock-picker is being dragged down by recent events too. The reason Equity Income fund investors have been running for the hills and withdrawing their money is that one after another Woodford’s share picks have been plunging. What if the share picks in the Woodford Patient Capital Trust are no good either?

Meanwhile, at the recent share price close to 56p, WPCT trades on a more-than-30% discount to the company’s own estimate of underlying net asset value. However, Rupert Hargreaves recently pointed out that most of the portfolio is invested in private companies rather than stock-market-listed firms. Private enterprises are hard to value, even though the trust has undertaken a number of independent valuations.

What if assumptions prove to be incorrect?

What if the estimates prove to be plain wrong? On top of that, what if the upside potential Woodford thinks he’s seeing in the enterprises he’s picked doesn’t materialise? Based on recent stock-picking performance, there’s every reason to suspect that Woodford could be ‘wrong’ about the investments in WPCT.

As investors ourselves, it’s risky enough trying to pick our own speculative ‘investments’. Often, things don’t work out as we hope and we end up losing money as share prices crash for one reason or another. So why add another layer of human judgement (or potential mis-judgement) to the stock-picking process by buying shares in a trust packed full of someone else’s speculative stock picks?

Despite the lure of a fat discount, I reckon the safest way is for me to avoid the shares of Woodford Patient capital Trust. It’s also a good idea for me to avoid profitless, speculative shares altogether and to focus on companies that have already proved their ability to turn a profit and increase it each year.

Should you invest, the value of your investment may rise or fall and your capital is at risk. Before investing, your individual circumstances should be assessed. Consider taking independent financial advice.

Kevin Godbold has no position in any share mentioned. The Motley Fool UK has no position in any of the shares mentioned. Views expressed on the companies mentioned in this article are those of the writer and therefore may differ from the official recommendations we make in our subscription services such as Share Advisor, Hidden Winners and Pro. Here at The Motley Fool we believe that considering a diverse range of insights makes us better investors.

More on Investing Articles

Investing Articles

How much would I need to invest in income shares to earn £300 a month?

What kind of lump sum would be required to earn £300 a month by taking advantage of some of the…

Read more »

Investing For Beginners

Up 31% in a month, could this FTSE 250 stock be getting bought out?

Jon Smith takes a look at speculation that's pushing the share price of a FTSE 250 share higher and considers…

Read more »

Investing Articles

Here’s how I’d follow Warren Buffett to start building passive income in 2025

Ben McPoland highlights one FTSE 250 firm with a strong competitive edge that he thinks can continue rewarding investors with…

Read more »

Investing Articles

Burberry shares: undervalued FTSE gems that are ready to rocket?

Burberry shares soared at the beginning of the week as the takeover rumour mill went into overdrive. Is Paul Summers…

Read more »

US Stock

Here are the latest share price forecasts for S&P 500 giant Amazon

Amazon has generated monster gains for investors over the last decade. And Wall Street analysts believe the S&P 500 stock…

Read more »

Man writing 'now' having crossed out 'later', 'tomorrow' and 'next week'
Investing Articles

2 high-yield FTSE 250 shares I’d buy today — and 1 that I’d avoid

UK markets have felt some volatility after last week’s Budget and the FTSE 250 was no stranger to it. Our…

Read more »

Investing Articles

3 reasons the Rolls-Royce share price could soar over the next decade

Sustainable aviation fuel, narrow-body aircraft, and small nuclear reactors could all keep the Rolls-Royce share price climbing over the next…

Read more »

British flag, Big Ben, Houses of Parliament and British flag composition
Investing Articles

Here’s how much income I’d get if I invested my entire £20k ISA in cheap BT shares

BT shares are on the up but still cheap, while the FTSE 100 telecoms stock offers a good yield too.…

Read more »